PL3242882T3 - Peptydy antagonistyczne wobec CGRP - Google Patents

Peptydy antagonistyczne wobec CGRP

Info

Publication number
PL3242882T3
PL3242882T3 PL16700059.5T PL16700059T PL3242882T3 PL 3242882 T3 PL3242882 T3 PL 3242882T3 PL 16700059 T PL16700059 T PL 16700059T PL 3242882 T3 PL3242882 T3 PL 3242882T3
Authority
PL
Poland
Prior art keywords
cgrp antagonist
antagonist peptides
peptides
cgrp
antagonist
Prior art date
Application number
PL16700059.5T
Other languages
English (en)
Inventor
Kazimierz Wisniewski
Guangcheng Jiang
Aleksandr K RABINOVICH
Javier J SUEIRAS-DIAZ
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of PL3242882T3 publication Critical patent/PL3242882T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
PL16700059.5T 2015-01-06 2016-01-06 Peptydy antagonistyczne wobec CGRP PL3242882T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562100371P 2015-01-06 2015-01-06
PCT/EP2016/050110 WO2016110499A1 (en) 2015-01-06 2016-01-06 Cgrp antagonist peptides

Publications (1)

Publication Number Publication Date
PL3242882T3 true PL3242882T3 (pl) 2022-10-31

Family

ID=55071041

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16700059.5T PL3242882T3 (pl) 2015-01-06 2016-01-06 Peptydy antagonistyczne wobec CGRP

Country Status (33)

Country Link
US (1) US9969775B2 (pl)
EP (1) EP3242882B1 (pl)
JP (1) JP6929227B2 (pl)
KR (1) KR102713739B1 (pl)
CN (1) CN107207567B (pl)
AR (1) AR103499A1 (pl)
AU (1) AU2016206059B2 (pl)
BR (1) BR112017013413A2 (pl)
CL (1) CL2017001761A1 (pl)
CO (1) CO2017007940A2 (pl)
DK (1) DK3242882T3 (pl)
EA (1) EA032082B1 (pl)
ES (1) ES2924410T3 (pl)
HR (1) HRP20220941T1 (pl)
HU (1) HUE059379T2 (pl)
IL (1) IL252903B (pl)
JO (1) JO3669B1 (pl)
LT (1) LT3242882T (pl)
MA (1) MA41311B1 (pl)
MD (1) MD3242882T2 (pl)
MX (1) MX387920B (pl)
MY (1) MY196439A (pl)
PH (1) PH12017501214A1 (pl)
PL (1) PL3242882T3 (pl)
PT (1) PT3242882T (pl)
RS (1) RS63467B1 (pl)
SA (1) SA517381865B1 (pl)
SG (1) SG11201705306UA (pl)
SI (1) SI3242882T1 (pl)
TN (1) TN2017000248A1 (pl)
TW (1) TWI717331B (pl)
UA (1) UA121490C2 (pl)
WO (1) WO2016110499A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200353088A1 (en) * 2017-11-06 2020-11-12 Auckland Uniservices Limited Peptide conjugate cgrp receptor antagonists and methods of preparation and uses thereof
WO2025202938A1 (en) 2024-03-26 2025-10-02 Nuvie Bio, Inc. Pharmaceutical composition comprising a cgrp receptor antagonist for the treatment of acute migraine
EP4647082A1 (en) 2024-05-08 2025-11-12 NUVIE BIO, Inc. Pharmaceutical composition comprising a cgrp receptor antagonist for the treatment of acute migraine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268474B1 (en) * 1998-04-30 2001-07-31 Creighton University Peptide antagonists of CGRP-receptor superfamily and methods of use
TW200533398A (en) 2004-03-29 2005-10-16 Bristol Myers Squibb Co Novel therapeutic agents for the treatment of migraine
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US7659264B2 (en) * 2004-10-07 2010-02-09 Merck Sharp & Dohme Corp. CGRP receptor antagonists
BRPI0606647A2 (pt) * 2005-01-17 2009-07-14 Jerini Ag antagonistas do receptor de c5a
EP1861399B1 (en) * 2005-03-14 2011-12-14 Merck Sharp & Dohme Corp. Cgrp receptor antagonists
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
SI3045182T1 (en) * 2005-11-14 2018-08-31 Teva Pharmaceuticals International Gmbh An antibody to a peptide-associated peptide antagonist to calcitonin for treating a headache in aggregates
EP2027106A2 (en) * 2006-06-13 2009-02-25 Vertex Pharmaceuticals Incorporated Cgrp receptor antagonists
EP2807187B1 (en) 2012-01-26 2017-07-26 Christopher J. Soares Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use

Also Published As

Publication number Publication date
MX387920B (es) 2025-03-19
ES2924410T3 (es) 2022-10-06
CN107207567A (zh) 2017-09-26
WO2016110499A1 (en) 2016-07-14
TW201630929A (zh) 2016-09-01
EA032082B1 (ru) 2019-04-30
CN107207567B (zh) 2021-11-23
KR20170102302A (ko) 2017-09-08
AR103499A1 (es) 2017-05-17
SA517381865B1 (ar) 2021-09-15
CL2017001761A1 (es) 2018-01-26
PH12017501214A1 (en) 2018-01-08
MD3242882T2 (ro) 2022-10-31
JO3669B1 (ar) 2020-08-27
CO2017007940A2 (es) 2017-10-31
US20180002378A1 (en) 2018-01-04
EP3242882B1 (en) 2022-05-04
DK3242882T3 (en) 2022-08-08
SG11201705306UA (en) 2017-07-28
HRP20220941T1 (hr) 2022-10-28
UA121490C2 (uk) 2020-06-10
EP3242882A1 (en) 2017-11-15
HUE059379T2 (hu) 2022-11-28
MA41311A (fr) 2017-11-14
PT3242882T (pt) 2022-08-09
LT3242882T (lt) 2022-08-25
JP2018505213A (ja) 2018-02-22
TN2017000248A1 (en) 2018-10-19
MY196439A (en) 2023-04-11
MA41311B1 (fr) 2022-10-31
MX2017008893A (es) 2017-10-25
NZ732771A (en) 2024-07-05
KR102713739B1 (ko) 2024-10-04
US9969775B2 (en) 2018-05-15
AU2016206059B2 (en) 2019-07-25
TWI717331B (zh) 2021-02-01
CA2973041A1 (en) 2016-07-14
JP6929227B2 (ja) 2021-09-01
IL252903B (en) 2021-01-31
IL252903A0 (en) 2017-08-31
RS63467B1 (sr) 2022-08-31
EA201791456A1 (ru) 2018-01-31
BR112017013413A2 (pt) 2018-01-09
AU2016206059A1 (en) 2017-07-20
SI3242882T1 (sl) 2022-09-30

Similar Documents

Publication Publication Date Title
IL258892B (en) Calcitonin gene-related peptide receptor antagonists
IL258893A (en) Cgrp receptor antagonists
ZA201800452B (en) Cgrp receptor antagonists
IL258894A (en) Cgrp receptor antagonists
GB201520539D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520546D0 (en) Peptides
GB201520536D0 (en) Peptides
GB201520545D0 (en) Peptides
GB201520544D0 (en) Peptides
IL252903A0 (en) cgrp antagonist peptides
GB201506316D0 (en) Novel peptide
GB201520541D0 (en) Peptides
GB201520542D0 (en) Peptides
GB201520557D0 (en) Peptides
GB201520548D0 (en) Peptides
GB201518700D0 (en) Peptides
ZA201704249B (en) Cgrp antagonist peptides
HK1239678A1 (en) Cgrp antagonist peptides
ZA201807767B (en) Angiotensin-1-receptor antagonists
PT3464324T (pt) Antagonistas de recetores da angiotensina-1
GB201520538D0 (en) Peptides
GB201520537D0 (en) Peptides
GB201520535D0 (en) Peptides
GB201520534D0 (en) Peptides